PREVEST
NSE: PREVEST

Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in

Start SIP

Key Statistics

Investment Rating

  • Master Rating:
  • Prevest Denpro has an operating revenue of Rs. 53.21 Cr. on a trailing 12-month basis. An annual revenue growth of 35% is outstanding, Pre-tax margin of 43% is great, ROE of 20% is exceptional. The company has a reasonable debt to equity of 2%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 6% and 12% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around -4% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 29 which is a POOR score indicating inconsistency in earnings, a RS Rating of 71 which is FAIR indicating the recent price performance, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 168 indicates it belongs to a poor industry group of Medical-Supplies and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Result Highlights

Synopsis

BSE-Medical-Supplies

Prevest Denpro belongs to the Industry of Medical Equipment & Accessories. Company’s Total Operating Revenue is Rs. 37.62 Cr. and Equity Capital is Rs. 12.00 Cr. for the Year ended 31/03/2022. Prevest Denpro Ltd. is a Public Limited Listed company incorporated on 05/05/1999 and has its registered office in the State of Jammu & Kashmir, India. Company’s Corporate Identification Number(CIN) is U85199JK1999PLC001969 and registration number is 001969.
Market Cap 477
Sales 33
Shares in Float 0.31
No of funds 3
Yield
Book Value 8.34
U/D Vol ratio 1.4
LTDebt / Equity 2
Alpha 0.3
Beta 1.34

Owner NameJun-22Mar-22
Promoters 73.6%73.6%
Foreign Portfolio Investors 0.66%0.76%
Financial Institutions/ Banks 1.16%1.21%
Individual Investors 21.47%21.06%
Others 3.11%3.37%

Management

Name Designation
Mr. Atul Modi Chairman & Managing Director
Mrs. Namrata Modi Whole Time Director
Dr. Sai Kalyan Surapaneni Executive Director
Ms. Niharika Modi Non Executive Director
Dr. Sudeep Murthy Independent Director
Dr. Nikhil Shrikant Bobade Independent Director

Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

FAQs

What is Share Price of ?

share price is ₹ As on 07 October, 2022 | 04:57

Q1FY23
Open Demat Account